Revvity, Inc.

Revvity, Inc. is a science-based solutions company working across life sciences and diagnostics, spanning the path from research discovery and development through to diagnosis. Headquartered in Waltham, Massachusetts, the company employs more than 11,000 people and serves customers in over 190 countries, with revenue exceeding $2.9 billion. It is part of the S&P 500 index.

The company's portfolio covers reagents, consumables, assays, scientific and diagnostic instruments, and Signals software, which supports decision-making between research and clinical customers. These are supplied to pharmaceutical and biotechnology firms, diagnostic laboratories, academia and government agencies. Technical work spans automation, multi-omics, preclinical research, translational science, laboratory instruments and software, and the development of assays and reagents.

Revvity positions itself as a translational business bridging research and clinical customers, with collaboration across automation, multi-omics and software forming part of its operating model. Its name combines “rev”, from “revolutionize”, and “vita”, Latin for life. The company was previously affiliated with PerkinElmer, Inc.